% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Galldiks:890616,
      author       = {Galldiks, Norbert and Niyazi, Maximilian and Grosu, Anca L
                      and Kocher, Martin and Langen, Karl-Josef and Law, Ian and
                      Minniti, Giuseppe and Kim, Michelle M and Tsien, Christina
                      and Dhermain, Frederic and Soffietti, Riccardo and Mehta,
                      Minesh P and Weller, Michael and Tonn, Jörg-Christian},
      title        = {{C}ontribution of {PET} imaging to radiotherapy planning
                      and monitoring in glioma patients - a report of the
                      {PET}/{RANO} group},
      journal      = {Neuro-Oncology},
      volume       = {23},
      number       = {6},
      issn         = {1523-5866},
      address      = {Oxford},
      publisher    = {Oxford Univ. Press},
      reportid     = {FZJ-2021-01076},
      pages        = {881–893},
      year         = {2021},
      abstract     = {The management of patients with glioma usually requires
                      multimodality treatment including surgery, radiotherapy, and
                      systemic therapy. Accurate neuroimaging plays a central role
                      for radiotherapy planning and follow-up after radiotherapy
                      completion. In order to maximize the radiation dose to the
                      tumor and to minimize toxic effects on the surrounding brain
                      parenchyma, reliable identification of tumor extent and
                      target volume delineation is crucial. The use of positron
                      emission tomography (PET) for radiotherapy planning and
                      monitoring in gliomas has gained considerable interest over
                      the last several years, but Class I data are not yet
                      available. Furthermore, PET has been used after radiotherapy
                      for response assessment and to distinguish tumor progression
                      from pseudoprogression or radiation necrosis. Here, the
                      Response Assessment in Neuro-Oncology (RANO) working group
                      provides a summary of the literature and recommendations for
                      the use of PET imaging for radiotherapy of patients with
                      glioma based on published studies, constituting levels 1-3
                      evidence according to the Oxford Centre for Evidence-based
                      Medicine.},
      cin          = {INM-3 / INM-4},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-3-20090406 / I:(DE-Juel1)INM-4-20090406},
      pnm          = {525 - Decoding Brain Organization and Dysfunction
                      (POF4-525)},
      pid          = {G:(DE-HGF)POF4-525},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {33538838},
      UT           = {WOS:000704008200008},
      doi          = {10.1093/neuonc/noab013},
      url          = {https://juser.fz-juelich.de/record/890616},
}